Literature DB >> 8296895

Mood disorders in HIV infection: prevalence and risk factors in a nonepicenter of the AIDS epidemic.

D O Perkins1, R A Stern, R N Golden, C Murphy, D Naftolowitz, D L Evans.   

Abstract

OBJECTIVE: The authors studied the lifetime, initial cross-sectional, and 6-month follow-up prevalence of mood disorders in asymptomatic HIV-infected and uninfected homosexual men who lived in an area with a low prevalence of HIV. They also determined the relationship between current major depression and potential depression risk factors.
METHOD: Subjects included 98 asymptomatic HIV-infected and 71 uninfected homosexual men. Subjects underwent extensive clinical, psychiatric, neuropsychological, and laboratory evaluations.
RESULTS: Similar proportions of HIV-infected and uninfected subjects reported a lifetime (29% and 45%, respectively), an initial current (8% and 3%), and a 6-month follow-up (9% and 11%) history of major depressive disorder. Anxiety disorders were less common, with similar proportions of HIV-infected and uninfected subjects reporting a lifetime (7% and 13%, respectively), an initial current (3% and 7%), and a 6-month follow-up (2% and 5%) history of anxiety disorders. There were no differences in the severity of mood symptoms between HIV-infected and uninfected subjects. Current major depression at initial visit was significantly associated with lifetime history of major depression but not with neuropsychological function or vitamin B12 level.
CONCLUSIONS: These findings are in agreement with previous studies of areas with a high prevalence of HIV. However, the proportion of subjects with mood disorders is high compared with general population studies. Both HIV-infected and uninfected homosexual men may be at high risk for major depression, especially if they have a past history of depression. Moreover, in the asymptomatic stage of HIV infection, major depression does not appear to be secondary to HIV central nervous system effects or low vitamin B12 levels.

Entities:  

Mesh:

Year:  1994        PMID: 8296895     DOI: 10.1176/ajp.151.2.233

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  38 in total

1.  Psychological aspects of living with HIV disease: a primary care perspective.

Authors:  R H Remien; J G Rabkin
Journal:  West J Med       Date:  2001-11

Review 2.  Neurological diseases and pain.

Authors:  David Borsook
Journal:  Brain       Date:  2011-11-08       Impact factor: 13.501

3.  Treatment of depression in HIV+men: Literature review and report of an ongoing study of testosterone replacement therapy.

Authors:  J G Rabkin; G Wagner; R Rabkin
Journal:  Ann Behav Med       Date:  1996-03

Review 4.  Treating depression within the HIV "medical home": a guided algorithm for antidepressant management by HIV clinicians.

Authors:  Julie L Adams; Bradley N Gaynes; Teena McGuinness; Riddhi Modi; James Willig; Brian W Pence
Journal:  AIDS Patient Care STDS       Date:  2012-11       Impact factor: 5.078

5.  Interrater reliability of the Psychiatric Research Interview for Substance and Mental Disorders in an HIV-infected cohort: experience of the National NeuroAIDS Tissue Consortium.

Authors:  S Morgello; C E Holzer; E Ryan; C Young; M Naseer; S A Castellon; A B Frol; J Hampton Atkinson; B B Gelman; I Grant; E J Singer
Journal:  Int J Methods Psychiatr Res       Date:  2006       Impact factor: 4.035

6.  Facing HIV as a family: predicting depressive symptoms with correlated responses.

Authors:  Li Li; Li-Jung Liang; Ying Ying Ding; Guoping Ji
Journal:  J Fam Psychol       Date:  2011-04

7.  Open-label, randomized, parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects.

Authors:  Russell E Poland; Lev Gertsik; Joya T Favreau; Shawnee I Smith; James M Mirocha; Uma Rao; Eric S Daar
Journal:  J Altern Complement Med       Date:  2012-10-25       Impact factor: 2.579

8.  A qualitative study of the feasibility and acceptability of a smoking cessation program for people living with HIV and emotional dysregulation.

Authors:  A K Labbe; J G Wilner; J N Coleman; S M Marquez; J D Kosiba; M J Zvolensky; J A J Smits; P J Norton; D Rosenfield; C O'Cleirigh
Journal:  AIDS Care       Date:  2018-10-23

9.  A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals.

Authors:  Steven A Safren; Conall O'Cleirigh; Judy Y Tan; Sudha R Raminani; Laura C Reilly; Michael W Otto; Kenneth H Mayer
Journal:  Health Psychol       Date:  2009-01       Impact factor: 4.267

10.  Neurocognitive impairment among HIV-positive individuals in Botswana: a pilot study.

Authors:  Kathy Lawler; Mosepele Mosepele; Sarah Ratcliffe; Esther Seloilwe; Katherine Steele; Rudo Nthobatsang; Andrew Steenhoff
Journal:  J Int AIDS Soc       Date:  2010-04-20       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.